Close

Tenax Therapeutics (TENX) to Review Strategic Alternatives; CEO Resigns

April 5, 2017 5:31 PM EDT Send to a Friend
Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login